Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001104659-21-099741

President and CEO bought 2,098 shares at $15.00 ($31,470)

  • President and CEO acquired 49,099 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Zeskind Benjamin J. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-03 Conversion : show line 1 in the form +49,099 2,598,171 D
2021-08-03 Purchase : show line 2 in the form +2,098 $15.00 $31,470 2,600,269 D
Open-market purchases · 2,098 sh · avg $15.00 · $31,470

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2021-08-03 Conversion : show line 3 in the form Series A Preferred Stock −40,928 40,928 0 D
2021-08-03 Conversion : show line 4 in the form Series B Preferred Stock −8,171 8,171 0 D
Loading xslF345X03/tm2123807-8_4seq1.xml…